Pioneering First Steps and Cautious Conclusions

Biological Psychiatry

Volumn 67, Issue 2, 2010, Pages 99-100

  McMahon, Francis J ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM;

ARTICLE; DEPRESSION; GENE NUMBER; GENETIC VARIABILITY; GENOTYPE; HUMAN GENOME; MAJOR DEPRESSION; PATIENT COMPLIANCE; PHARMACOGENETICS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 71949104703     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2009.11.010     Document Type: Note

References (20)

1. Trivedi M.H., Rush A.J., Wisniewski S.R., Nierenberg A.A., Warden D., Ritz L., et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice. Am J Psychiatry 163 (2006) 28-40
2. Garriok H.A., Kraft J.B., Shyn S.I., Peters E.J., Yokoyama J.S., Jenkins G.D., et al. A genome-wide association study of citalopram response in major depressive disorder. Biol Psychiatry 67 (2010) 133-138
3. Manolio T.A., Brooks L.D., and Collins F.S. A HapMap harvest of insights into the genetics of common disease. J Clin Invest 118 (2008) 1590-1605
4. Maher B.S., Riley B.P., and Kendler K.S. Psychiatric genetics gets a boost. Nat Genet 40 (2008) 1042-1044
5. Binder E.B., Salyakina D., Lichtner P., Wochnik G.M., Ising M., Pütz B., et al. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet 36 (2004) 1319-1325
6. McMahon F.J., Buervenich S., Charney D., Lipsky R., Rush A.J., Wilson A.F., et al. Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment. Am J Hum Genet 78 (2006) 804-814
7. Paddock S., Laje G., Charney D., Rush A.J., Wilson A.F., Sorant A.J., et al. Association of GRIK4 with outcome of antidepressant treatment in the STAR*D cohort. Am J Psychiatry 164 (2007) 1181-1188
8. Perlis R.H., Moorjani P., Fagerness J., Purcell S., Trivedi M.H., Fava M., et al. Pharmacogenetic analysis of genes implicated in rodent models of antidepressant response: Association of TREK1 and treatment resistance in the STAR(*)D study. Neuropsychopharmacology 33 (2008) 2810-2819
9. Uhr M., Tontsch A., Namendorf C., Ripke S., Lucae S., Ising M., et al. Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression. Neuron 57 (2008) 203-209
10. Laje G., Paddock S., Manji H., Rush A.J., Wilson A.F., Charney D., and McMahon F.J. Genetic markers of suicidal ideation emerging during citalopram treatment of major depression. Am J Psychiatry 164 (2007) 1530-1538
11. Ge D., Fellay J., Thompson A.J., Simon J.S., Shianna K.V., Urban T.J., et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461 (2009) 399-401
12. Daly A.K., Donaldson P.T., Bhatnagar P., Shen Y., Pe'er I., Floratos A., et al. HLA-B* 5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat Genet 41 (2009) 816-819
13. Laje G., Perlis R.H., Rush A.J., and McMahon F.J. Pharmacogenetics studies in STAR*D: Strengths, limitations, and results. Psychiatr Serv 60 (2009) 1446-1457
14. Kato M., and Serretti A. Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder. [published online ahead of print Nov 4]. Mol Psychiatry (2008)
15. Ising M., Lucae S., Binder E.B., Bettecken T., Uhr M., Ripke S., et al. A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression. Arch Gen Psychiatry 66 (2009) 966-975
16. Evaluation of Genomic Applications in PracticePrevention (EGAPP) Working Group. Recommendations from the EGAPP Working Group: Testing for cytochrome P450 polymorphisms in adults with nonpsychotic depression treated with selective serotonin reuptake inhibitors. Genet Med 9 (2007) 819-825
17. Uher R., Huezo-Diaz P., Perroud N., Smith R., Rietschel M., Mors O., et al. Genetic predictors of response to antidepressants in the GENDEP project. Pharmacogenomics J 9 (2009) 225-233
18. Klein T.E., Altman R.B., Eriksson N., Gage B.F., Kimmel S.E., et al., International Warfarin Pharmacogenetics Consortium. Estimation of the warfarin dose with clinical and pharmacogenetic data. N Engl J Med 360 (2009) 753-764
19. Fava M., Rush A.J., Alpert J.E., Balasubramani G.K., Wisniewski S.R., Carmin C.N., et al. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: A STAR*D report. Am J Psychiatry 165 (2008) 342-351
20. Leuchter A.F., Cook I.A., Gilmer W.S., Marangell L.B., Burgoyne K.S., Howland R.H., et al. Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder. Psychiatry Res 169 (2009) 132-138